Detalles de la búsqueda
1.
FDG-PET/CT findings in systemic mastocytosis: a French multicentre study.
Eur J Nucl Med Mol Imaging
; 42(13): 2013-20, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26140850
2.
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
Ann Hematol
; 92(5): 621-31, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23358617
3.
Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome.
J Eur Acad Dermatol Venereol
; 24(10): 1171-5, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20202054
4.
[Immune-related adverse events after immune checkpoints inhibitors in 2019: An update]. / Toxicités immunologiques induites par les inhibiteurs de checkpoint en 2019 : mise au point.
Rev Med Interne
; 41(1): 37-45, 2020 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-31668882
5.
[Management of myelodysplastic syndromes in 2019: An update]. / Prise en charge des syndromes myélodysplasiques en 2019 : mise au point.
Rev Med Interne
; 40(9): 581-589, 2019 Sep.
Artículo
en Francés
| MEDLINE | ID: mdl-31054780
6.
Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells.
Leukemia
; 21(11): 2304-10, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17713555
7.
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.
J Thromb Haemost
; 16(9): 1830-1842, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978544
8.
Bone marrow involvement in systemic lupus erythematosus.
QJM
; 110(11): 701-711, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28525589
9.
[Anti PM-Scl antibodies. Study of prevalence and of meaning]. / Autoanticorps anti-PM-Scl. Etude de prévalence et de signification.
Rev Med Interne
; 27(9): 665-70, 2006 Sep.
Artículo
en Francés
| MEDLINE | ID: mdl-16797795
10.
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion.
Leukemia
; 30(4): 897-905, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26500139
11.
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.
Leuk Res
; 39(8): 859-65, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26120100
12.
[Anti-Ku antibodies. Study of prévalence and of clinical meaning]. / Auto-immunité anti-Ku. Etude de prévalence et de signification clinique.
Rev Med Interne
; 25(9): 619-22, 2004 Sep.
Artículo
en Francés
| MEDLINE | ID: mdl-15363616
13.
Impact of an oncogeriatric consulting team on therapeutic decision-making.
J Nutr Health Aging
; 17(5): 473-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23636550
14.
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents.
Leukemia
; 27(6): 1283-90, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23370672
15.
Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
Cancer Imaging
; 12: 7-12, 2012 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-22275725
16.
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
Leuk Res
; 36(4): 397-400, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22177456
17.
Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.
Blood Cancer J
; 7(5): e562, 2017 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28498370
18.
[Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]. / Profil des anticorps antiphospholipides et risque de thrombose : étude comparative entre thrombopénie immunologique chronique et syndrome des antiphospholipides primaire.
Rev Med Interne
; 32(12): 724-9, 2011 Dec.
Artículo
en Francés
| MEDLINE | ID: mdl-21864953
19.
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS.
Leuk Res
; 35(11): 1530-3, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21803419
20.
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
Leukemia
; 25(7): 1147-52, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21494260